Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils

The Journal of Infectious Diseases
C C CorriveauRobert L Danner

Abstract

The effects of nitric oxide (NO) on human neutrophil chemotactic responses and release of interleukin (IL)-8 was studied. Neutrophils exposed to chemoattractants (IL-8, FMLP, leukotriene B4, and C5a) failed to show increases in intracellular guanosine 3',5'-cyclic monophosphate (cGMP), an indicator of NO production. Although NO increased cGMP in neutrophils, neither of two NO donors (sodium nitroprusside and 3-morpholino-sydonimine) nor a NO synthase inhibitor (N omega-nitro-L-arginine) altered FMLP- or IL-8-elicited neutrophil chemotaxis (P > .25 for all). However, lipopolysaccharide-induced IL-8 production was increased in a dose-dependent manner by a combination of sodium nitroprusside and N-acetylcysteine (P = .03) or by S-nitrosoglutathione (P = .004). NO-augmented IL-8 release was not reproduced by treating neutrophils with dibutyryl-cGMP. Up-regulation of IL-8 release by NO was associated with increased IL-8 mRNA levels (P = .009). These data suggest that NO does not directly affect neutrophil chemotaxis but may indirectly alter chemotactic responses by increasing IL-8 production via a cGMP-independent pathway.

Citations

Jun 21, 2001·Archives of Biochemistry and Biophysics·S K SaxenaR C Srivastava
Dec 8, 2000·Thrombosis Research·S Sethi, M Dikshit
Jun 1, 1997·Alimentary Pharmacology & Therapeutics·S FiorucciA Morelli
Apr 13, 2000·International Journal of Experimental Pathology·S K SaxenaA Mathur
Nov 11, 1998·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·T OdaN Mukaida
Nov 5, 2005·BMC Genomics·Xiaolin CuiRobert L Danner
May 5, 2009·Biochemical Pharmacology·Rodrigo MedeirosJoão B Calixto
Jun 2, 2009·Journal of Endodontics·Fernanda Geraldes PappenRenato de Toledo Leonardo
Nov 27, 2014·Frontiers in Cellular Neuroscience·Franca OrsiniMaria-Grazia De Simoni
Feb 26, 2009·FEMS Immunology and Medical Microbiology·Umesh C Chaturvedi, Rachna Nagar
Jun 19, 2014·Molecular Immunology·Valentina CalabreseFrancesco Peri
Apr 30, 2008·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Kyung-San MinEun-Cheol Kim
Aug 20, 2014·Archives of Biochemistry and Biophysics·Alessandro CortiAlfonso Pompella
Jan 2, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anetta PtasinskaRobert L Danner
May 15, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Hong HuangJean-Pierre Lavoie
Jul 1, 2004·The Journal of Pharmacology and Experimental Therapeutics·Kerryn McCluskieMaria G Belvisi
Dec 17, 2019·Journal of Leukocyte Biology·J HannS Bréchard
Oct 21, 1999·The Journal of Pharmacy and Pharmacology·H Zhou, S Mineshita
May 22, 2003·The Journal of Biological Chemistry·Jianhua ZhangRobert L Danner
Nov 15, 2001·Journal of Neuropathology and Experimental Neurology·U KoedelH W Pfister
Jan 5, 2002·Journal of Endodontics·H ShimauchiH Okada
Aug 5, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Darrell SalinasVijayakumar Boggaram

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.